Condition
T-Cell Dysfunction
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06684054Not Yet RecruitingPrimary
Studying the Senescent T Cell Features and Its Relationship with the Chemotherapy Efficacy in Young TNBC
NCT05886738Not ApplicableUnknown
Investigating the Effect of Short-term Fasting on T Cell Metabolism, Function, and Phenotype in Obesity
NCT04658069Unknown
T Cell Dysfunction in ESRD
Showing all 3 trials